Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus

Dengue virus (DENV) presents a significant threat to global public health with more than 500,000 hospitalizations and 25,000 deaths annually. Currently, there is no clinically approved antiviral drug to treat DENV infection. The envelope (E) glycoprotein of DENV is a promising target for drug discov...

Descripción completa

Detalles Bibliográficos
Autores principales: Anasir, Mohd Ishtiaq, Ramanathan, Babu, Poh, Chit Laa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232406/
https://www.ncbi.nlm.nih.gov/pubmed/32225021
http://dx.doi.org/10.3390/v12040367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232406/
https://www.ncbi.nlm.nih.gov/pubmed/32225021
http://dx.doi.org/10.3390/v12040367

Ejemplares similares